Buys
Open market- Shares
- +83,968
- Avg price
- $20.84
- Total value
- +$1,749,660
Clay B. Siegall - President and CEO, Director at Immunome Inc.
Issuer-level insider activity
- Role
- President and CEO, Director
- Issuer ticker
- IMNM on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Clay B. Siegall in Immunome Inc.
Sells
Open market- Shares
- Avg price
- Total value
Net
Past year- Shares
- +83,968
- Share %
- 100%
- Total value
- +$1,749,660
Reported holdings for Clay B. Siegall in Immunome Inc.
Form 4 holding
President and CEO, Director
Immunome Inc.
- Security class
- Common Stock
- Shares / value
- 870,704
- Estimated value
- $18,450,217
- Report date
- 23 Jul 2026
- Price
- $21.19
- Ownership
- Direct
Form 4 holding
President and CEO, Director
Immunome Inc.
- Security class
- Employee Stock Option (right to buy)
- Shares / value
- 360,000
- Estimated value
- Report date
- 23 Jul 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Clay B. Siegall in Immunome Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.